• Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth simplywall.st Tue, 07 Jul 2026 10:19:15 GMT
• Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11 Moomoo Wed, 01 Jul 2026 06:56:53 GMT
• enterprise value to ebitda forward of nkarta, inc. – nasdaq:nktx TradingView Tue, 30 Jun 2026 19:55:54 GMT
• nkarta sets june 30 fireside chat on car-nk autoimmune therapy Stock Titan Tue, 30 Jun 2026 18:00:00 GMT
• Nkarta at H.C. Wainwright cell therapy conference: autoimmune push Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs Sahm Tue, 30 Jun 2026 07:00:00 GMT
• Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference GlobeNewswire Fri, 26 Jun 2026 12:45:00 GMT
• Nkarta sets June 30 fireside chat on CAR-NK autoimmune therapy Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• phil nadeau reiterates buy on nkarta, citing differentiated nk cell platform and cd19 car nk therapy as key long-term value driver... TipRanks Tue, 23 Jun 2026 10:15:07 GMT
• TD Cowen initiates Nkarta stock with buy rating on NK cell therapy Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Nkarta (NKTX) CEO reports 1,776-share tax-related sale, holds 390,247 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• nkarta inc (nktx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 22:52:38 GMT
• nkarta inc (nktx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 19:26:38 GMT
• nkarta inc (nktx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 19:19:24 GMT
• nktx q1 2026 earnings: narrower loss beats estimates amid clinical progress - earnings season preview newsline.com Wed, 17 Jun 2026 18:35:08 GMT
• nkarta inc (nktx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 09:57:33 GMT
• nkarta inc (nktx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 09:57:26 GMT
• nkarta inc (nktx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 09:54:22 GMT
• nkarta inc (nktx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 09:31:37 GMT
• nkarta inc (nktx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 09:31:32 GMT
• NKTX Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Shares - Upward Estimate Revision dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• nkarta shareholders back directors, auditor and annual say-on-pay The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
• nktx q1 2026 earnings: narrower-than-expected loss and promising pipeline updates spark 12% rally newsline.com Fri, 12 Jun 2026 00:44:21 GMT
• Nkarta (NKTX) director George Simeon awarded 37,000-share stock option grant Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Nkarta (NKTX) investors approve directors, auditor and annual say-on-pay Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Nkarta (NKTX) director awarded 37,000 stock options vesting in 2027 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Nkarta (NKTX) director granted 37,000 stock options for RA Capital funds Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Nkarta director granted options on 37,000 shares | NKTX Insider Trading Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• nkarta (nasdaq: nktx) reports 37,000-share option grant tied to ra capital Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• nkarta shareholders back directors, auditor and annual say-on-pay TipRanks Thu, 11 Jun 2026 07:00:00 GMT
• nkarta (nktx) director angela thedinga awarded 37,000 stock options Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• nkarta (nktx) director awarded stock options for 37,000 shares at $2.46 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• nkarta (nktx) director receives stock options on 37,000 common shares Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• nktx q1 2026 earnings: narrower-than-expected loss as pre-revenue biotech advances pipeline - profit guidance range dars.gov.et Wed, 10 Jun 2026 07:00:00 GMT
• nkarta inc. (nktx) edges lower: assessing support and resistance in a volatile biotech market - defined outcome etf newsline.com Tue, 09 Jun 2026 15:47:03 GMT
• nkarta (nasdaq:nktx) is in a good position to deliver on growth plans Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• nkarta inc. (nktx) edges higher on above-average volume, nears key resistance - dealer positioning newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Wed, 03 Jun 2026 10:02:35 GMT
• NKTX Q1 2026 Earnings: Narrower-than-Expected Loss Amid Clinical Progress - Consensus Beat Rate dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Tue, 02 Jun 2026 00:26:20 GMT
• Expanding Access To Cell Therapy Trials Beyond AMCs And Into The Community Clinical Leader Mon, 01 Jun 2026 07:00:00 GMT
• nktx q1 2026 earnings: narrower-than-expected loss lifts shares - earnings quality analysis newsline.com Fri, 29 May 2026 07:00:00 GMT
• nkarta inc. (nktx) rallies 3.45% as buyers defend key support level - sign of strength thelegaladvocate.com Thu, 28 May 2026 20:37:31 GMT
• nkarta inc. (nktx) advances 4.25% as biotech sector momentum builds - call wall The Legal Advocate Thu, 28 May 2026 01:40:47 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Wed, 27 May 2026 19:18:18 GMT
• nkarta inc. (nktx) advances 4.25% as biotech sector momentum builds - fibonacci arc newsline.com Wed, 27 May 2026 07:00:00 GMT
• nkarta inc. (nktx) q1 2026 earnings: narrower loss surprises as pre-revenue biotech advances pipeline The Legal Advocate Tue, 26 May 2026 01:44:31 GMT
• nkarta inc. (nktx) q1 2026 earnings: narrower loss surprises as pre-revenue biotech advances pipeline - analyst drop coverage newsline.com Mon, 25 May 2026 07:00:00 GMT
• nkarta inc. (nktx) holds steady at $3.03 as market awaits catalyst - expert stock picks Newser Fri, 22 May 2026 19:41:42 GMT
• nkarta (nktx) posts record q1 2026 — eps $-0.37 blows past estimates - quarterly earnings The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• nea (nktx) drops below 5% ownership in latest schedule 13d/a filing Stock Titan Tue, 19 May 2026 07:00:00 GMT
• nkarta (nktx) stock: jumps +1.52%, approaching $2.81 2026-05-18 - {涓偂鍓爣棰榼 Newser Mon, 18 May 2026 22:02:05 GMT
• evercore initiates nkarta(nktx.us) with buy rating, announces target price $9 Moomoo Mon, 18 May 2026 07:00:00 GMT
• Nkarta Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$201m simplywall.st Fri, 15 May 2026 07:00:00 GMT
• Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• nkarta (nktx) stock today: drops -3.27%, key support at $2.81 2026-05-14 - volume dry up newsline.com Thu, 14 May 2026 07:00:00 GMT
• Nkarta, Inc. Stock 12‑Month Price Target Raised to $11.8, Implies 260% Upside TradingView Wed, 13 May 2026 07:00:00 GMT
• Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11 富途牛牛 Wed, 13 May 2026 07:00:00 GMT
• stifel maintains nkarta(nktx.us) with buy rating, maintains target price $11 富途牛牛 Wed, 13 May 2026 07:00:00 GMT
• h.c. wainwright maintains nkarta(nktx.us) with buy rating, maintains target price $16 Moomoo Wed, 13 May 2026 07:00:00 GMT
• nkarta price target maintained with a $11.00/share by needham Moomoo Wed, 13 May 2026 07:00:00 GMT
• nkarta buy rating reaffirmed as nkx019 autoimmune trials advance; $16 price target maintained TipRanks Wed, 13 May 2026 07:00:00 GMT
• nkarta reports $367.8 million in cash reserves for first quarter 2026 geneonline.com Tue, 12 May 2026 21:40:22 GMT
• nkarta (nasdaq:nktx) q1 2026 narrower loss beats estimates as autoimmune trial advances ChartMill Tue, 12 May 2026 20:41:59 GMT
• Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• nkarta, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• nkarta inc reports results for the quarter ended march 31 - earnings summary TradingView Tue, 12 May 2026 07:00:00 GMT
• fda deal lets nkarta test autoimmune cell therapy in community clinics Stock Titan Tue, 12 May 2026 07:00:00 GMT
• nkarta (nktx) q1 2026 results: nkx019 trial progress and cash runway into 2029 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• nkarta (nasdaq: nktx) q1 2026 loss narrows as cash reaches $266.7m Stock Titan Tue, 12 May 2026 07:00:00 GMT
• how nkarta (nktx) performance compares to expectations (momentum fading) 2026-05-08 - quote data newsline.com Fri, 08 May 2026 07:00:00 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Fri, 01 May 2026 22:46:49 GMT
• nkarta, inc. (nasdaq:nktx) given average rating of "hold" by analysts MarketBeat Fri, 01 May 2026 07:01:25 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Wed, 29 Apr 2026 16:10:02 GMT
• nktx nkarta reports wider than expected q4 2025 loss, shares fall nearly 3% on weak investor sentiment. newsline.com Wed, 29 Apr 2026 07:00:00 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Sun, 26 Apr 2026 03:31:16 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Thu, 23 Apr 2026 13:48:47 GMT
• executive pay, auditor and board elections on ballot at nkarta (nktx) 2026 virtual meeting Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• nktx (nkarta inc.) reports wider than expected q4 2025 loss, shares jump nearly 16 percent on upbeat investor sentiment. - retail ... Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 20:34:18 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Wed, 22 Apr 2026 11:12:16 GMT
• nktx stock up on upbeat regulatory update on lead autoimmune program MSN Tue, 21 Apr 2026 09:54:44 GMT
• nkarta cell therapy trial may soon offer outpatient treatment option in aav ANCA Vasculitis News Mon, 20 Apr 2026 07:00:00 GMT
• nkarta (nktx) stock dividend safety (underperforming) 2026-04-20 - wave equality The Legal Advocate Mon, 20 Apr 2026 07:00:00 GMT
• nkarta (nktx) stock: why it could change (in focus) 2026-04-18 - cash flow strong stocks The Legal Advocate Sat, 18 Apr 2026 07:00:00 GMT
• nkarta (nktx) stock: is it stabilizing (in focus) 2026-04-18 - stock buy zone newsline.com Sat, 18 Apr 2026 07:00:00 GMT
• nkarta receives fda agreement for outpatient nkx019 dosing by investing.com Investing.com India Fri, 17 Apr 2026 10:32:05 GMT
• What date does Nkarta's (NKTX) report Earnings - Earnings Calendar & Announcement Zacks Investment Research Fri, 17 Apr 2026 07:00:00 GMT
• NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program Yahoo Finance Fri, 17 Apr 2026 07:00:00 GMT
• nkarta (nktx): constructive buy rating on leadership, strategic positioning, and upcoming value-creating milestones TipRanks Thu, 16 Apr 2026 14:39:16 GMT
• stifel maintains nkarta(nktx.us) with buy rating, maintains target price $11 Moomoo Thu, 16 Apr 2026 14:31:00 GMT
• needham maintains nkarta(nktx.us) with buy rating, maintains target price $11 Moomoo Thu, 16 Apr 2026 13:30:50 GMT
• h.c. wainwright maintains nkarta(nktx.us) with buy rating, maintains target price $16 富途牛牛 Thu, 16 Apr 2026 10:37:01 GMT
• Nkarta wins FDA nod for new trial protocol (NKTX:NASDAQ) Seeking Alpha Thu, 16 Apr 2026 07:00:00 GMT
• nktx (nkarta inc.) reports wider than expected q4 2025 loss, shares jump nearly 16 percent on upbeat investor sentiment. - eps gro... newsline.com Thu, 16 Apr 2026 07:00:00 GMT
• nkarta announces fda agreement on outpatient dosing of nkx019 in autoimmune disease, expanding access to community rheumatology ce... The Manila Times Thu, 16 Apr 2026 07:00:00 GMT
• nkarta receives fda agreement for outpatient nkx019 dosing by investing.com Investing.com India Thu, 16 Apr 2026 07:00:00 GMT
• nktx: pivot to off-the-shelf car-nk therapy in autoimmune diseases, with broad trials and strong cash runway TradingView Wed, 15 Apr 2026 21:28:23 GMT
• nkarta announces agreement with fda on changes to ntrust-1, ntrust-2 trials TipRanks Wed, 15 Apr 2026 20:43:02 GMT
• nkarta reports fda agreement on outpatient dosing of nkx019 marketscreener.com Wed, 15 Apr 2026 20:33:14 GMT
• Nkarta Announces FDA Agreement on Outpatient Dosing of GlobeNewswire Wed, 15 Apr 2026 07:00:00 GMT
• nkarta receives fda agreement for outpatient nkx019 dosing Investing.com Wed, 15 Apr 2026 07:00:00 GMT
• nkarta targets 2-hour monitoring, not overnight stays, in cell therapy trials Stock Titan Wed, 15 Apr 2026 07:00:00 GMT
• nkarta announces agreement with the u.s. food and drug administration (fda) on outpatient dosing protocol of nkx019 for the treatm... Bitget Wed, 15 Apr 2026 07:00:00 GMT
• ceo moves: will nkarta inc stock benefit from m a - 2026 investor takeaways & technical pattern alert system baoquankhu1.vn Mon, 13 Apr 2026 09:09:50 GMT
• aug postearnings: is nkarta inc stock suitable for long term investing - 2026 big picture & free ai powered buy and sell recommend... baoquankhu1.vn Fri, 10 Apr 2026 16:10:19 GMT
• nkarta to participate in needham virtual healthcare conference GlobeNewswire Thu, 09 Apr 2026 07:00:00 GMT
• nkarta leaders to discuss autoimmune cell therapy at needham event Stock Titan Thu, 09 Apr 2026 07:00:00 GMT
Nkarta, Inc(NASDAQ:NKTX) 
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p...
Website: http://www.nkartatx.com
Founded: 2015
CEO: Paul J. Hastings
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends